Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company AbbVie Inc.
DescriptionAntibody-drug conjugate targeting ephrin-A4 (EFNA4; EFL4)
Molecular Target Ephrin-A4 (EFNA4) (EFL4)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation
PartnerPfizer Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today